in the drinking water of the two communities were stated to be similar.
Subjects were selected
randomly from a pool that included every person 18 years of age or older. The response rate is
unknown. All subjects underwent three blood pressure measurements (taken over a 20-minute
period with a calibrated electronic blood pressure apparatus) and responded to a health
questionnaire that included such variables as sex, age, weight, height, smoking habits, family
history, occupation, medication, and physician-diagnosed heart disease, stroke, and renal disease.
Data were evaluated by analysis of variance and adjusted for age and sex. The West Dundee
study population included 506 males and 669 females. The McHenry study population included
532 males and 671 females. The ages of both populations ranged from 18 to 75 and older.
No significant differences in mean systolic or diastolic blood pressures or in rates of
hypertension, heart disease, stroke, or kidney disease were observed between the two
communities. Since no differences were observed between the populations of these two
communities, a subpopulation of the McHenry and West Dundee subjects who did not have
home water softeners, were not taking medication for hypertension, and had lived in the study
community for more than 10 years was evaluated. There were 85 subjects from each community
in this subpopulation. No significant differences were observed between these two
subpopulations for any of the endpoints measured.
4.1.2. Case Reports Following Oral Exposure
There are numerous case reports of accidental or intentional ingestion of soluble barium
salts (Centers for Disease Control [CDC], 2003; Koch et al., 2003; Jacobs et al., 2002; Jourdan et
al., 2001; Koley et al., 2001; Thomas et al., 1998; Downs et al., 1995; Deng et al., 1991; Jan et
al., 1991; Schorn et al., 1991; Dhamija et al., 1990; Tenenbein, 1985). Reported effects included
gastroenteritis, hypokalemia, acute hypertension, cardiac arrhythmia, skeletal muscle paralysis,
and death (CDC, 2003; Jacobs et al., 2002; Deng et al., 1991; Schorn et al., 1991; Roza and
Berman, 1971). Acute renal failure was reported in a case of barium poisoning in which the
patient was treated with intravenous sulfate (Wetherill et al., 1981). The patient had been “spree
drinking” laboratory ethanol over the course of a week and then ingested approximately 13 g of
barium chloride with suicidal intent. Eight hours after ingestion of the barium salt, the patient
experienced progressive paralysis and was treated with oral and intravenous magnesium sulfate
and potassium replacement. Barium serum concentrations were not measured. On the third
hospital day, urine output dropped despite forced diuresis, and blood urea nitrogen (BUN) and
creatinine levels rose dramatically. Renal tubular cells and granular casts were recovered from
urine sediment. Nephrotomograms detected curvilinear barium deposition in the renal calyceal
11
system, which resolved over the course of a week. Acute tubular necrosis was apparently caused
by precipitated barium sulfate, which obstructed the renal tubules.
4.1.3. Inhalation Exposure
The data base on the toxicity of inhaled barium compounds in humans consists primarily
of studies of occupational exposure to barium sulfate or barite ore or to unspecified soluble
barium compounds. Several case reports (e.g., Seaton et al., 1986; Pendergrass and Greening,
1953) and a prospective study conducted by Doig (1976) have reported baritosis in barium-
exposed workers. Baritosis is considered a benign pneumoconiosis resulting from the inhalation
of barite ore or barium sulfate. The most outstanding feature of baritosis is the intense
radiopacity of the discrete opacities that are usually profusely disseminated throughout the lung
fields; in some cases the opacities may be so numerous that they appear confluent. The Third
Conference of Experts on Pneumoconiosis (American Conference of Governmental Industrial
Hygienists [ACGIH], 1992) noted that barium sulfate produced a noncollagenous type of
pneumoconiosis in which there is a minimal stromal reaction that consists mainly of reticulin
fibers, intact alveolar architecture, and potentially reversible lesions. The available human data
on baritosis suggest that the accumulation of barium in the lungs does not result in medical
disability or symptomatology. A decline in the profusion and opacity density, suggesting a
decrease in the amount of accumulated barium in the lung, has been observed several years after
termination of exposure. Studies by the National Institute for Occupational Safety and Health
(NIOSH, 1982) and Zschiesche et al. (1992) on soluble barium compounds did not include
radiography; these studies focused on the potential for barium to induce systemic effects (e.g.,
increases in blood pressure, kidney effects, electrocardiogram [EKG] alterations).
Doig (1976) conducted a prospective study on workers at a barite grinding facility.
During the initial investigation in 1947, five workers employed for more than 3.5 years were
examined. No evidence of baritosis was observed in any of the workers. In 1961, eight workers
(26-45 years of age, mean of 32) employed for 3.5-18 years (mean of 9) were examined (one of
these workers was also examined in 1947). Seven of the workers reported no respiratory
symptoms; one worker reported a slight occasional cough. No abnormal symptoms were noted
during the physical examination of seven of the workers; crepitations dispelled by cough were
observed in one worker (not the same worker reporting an occasional cough). Pneumoconiosis
was detected in the radiographs of seven workers. Three other workers employed for 1 month to
1 year were also examined in 1961. Two of these workers reported having slight coughs, but no
abnormal findings were observed during the physical examination and the chest radiographs
were normal. At this time, dust concentrations, ranging from 2734 to 11,365 particles per mL,
12